General Secretary of the CPC Central Committee, President of the People’s Republic of China and Chairman of the CPC Central Military Commission Hu Jintao (C) conferred the 2010 State Top S&T Award to Academician Wang Zhenyi (L) of the Chinese Academy of Engineering, and Academician Shi Changxu (R) of the Chinese Academy of Sciences and the Chinese Academy of Engineering. (Xinhua News Agency)
Secretary Ma Dexiu and Academician Wang Zhenyi (the fourth from the right), and some SJTU prize-winners
On January 14, 2011, the awarding ceremony of the State Supreme Science and Technology Prize was held by the Central Committee of the Chinese Communist Party and the State Council in Beijing. Leaders of the state and the Chinese Communist Party (CCP) including Hu Jintao, Wen Jiaobao, Li Changchun, Xi Jinping and Li Keqiang were present at the ceremony. Professor Wang Zhenyi, renowned hematologist and academician of the Chinese Academy of Engineering from Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU), won the State Supreme Science and Technology Prize. Another 10 projects of SJTU were also awarded the Prizes of State Science and Technology. Ma Dexiu, the SJTU Party Committee Secretary, and some prize winners attended the awarding ceremony in Beijing.
In a warm round of applause, Hu Jintao, General Secretary of the Central Committee of the CCP, National Chairman of the PRC and Chairman of the Central Military Commission, conferred the award certificate to Professor Wang Zhenyi, shook his hands and took a photo with him.
Professor Wang Zhenyi was born in November 1924 in Shanghai, with his ancestral hometown in Xinghua, Jiangsu Province. He graduated from Aurora University in 1948. He is now an academician of the Chinese Academy of Engineering, tenured professor of Ruijin Hospital Affiliated to SJTU and Honorary Director of the Shanghai Institute of Hematology.
Professor Wang Zhenyi succeeded in transforming malignant cells into benign ones in the clinical treatment of leukemia. This new strategy laid the clinical basis for the induction differentiation theory. He established the internationally-recognized leukemia treatment known as “Shanghai Program,” stated its genetic basis and molecular mechanism, set an example for the integration of basic and clinic medicine, and established the research system for the clinical application of thrombosis and hemostasis in China. He became the foreign member of the French Academy of Sciences in 1992 and won the Knight Legion of Honor in 1993. He was elected the academician of the Chinese Academy of Engineering and won the highest award in the international oncology community—Kettering Prize in 1994. After that he also received the Swiss Charles Rodolphe Brupbacher Prize for his “extraordinary contributions to basic oncological research” and the French Prix modial Cino Del Duca for Science. He obtained his honorary doctoral degree from Columbia University in 2001. In 2003, he was the first Asian to present a special report at the annual conference of the American Society of Hematology and won the Ham-Wasserman award.
In 1988, Academician Wang Zhenyi published the first paper about the clinical application of ATRA in the magazine Blood, which aroused strong repercussions in the international hematology field, and set off a new climax of the research on inducing differentiation. Till May 2010, this paper has been widely cited for 1713 times. In 2000, the paper was awarded the the ISI Citation Classic Award of the year as one of the 1981-1998 most cited papers in the world. In the same year, the book Hematology: Landmark Papers of the Twentieth Century included this paper as one of the 86 most influential papers in the twentieth century all over the world.
Professor Wang has won 23 national and provincial-level technology prizes, and has published over 320 papers since 1980, acted as the chief editor of five books and participated in the compilation of 17 books, among which the book Treatment for Tumor by Inducing Differentiation and Apoptosis he co-edited with Chen Zhu won the first prize of National Publication; the book The Basic Theory and Clinical Study of Thrombosis and Hemostasis he co-edited with Li Jiazeng and Ruan Changgeng has issued three editions (the 3rd edition in 1994) and become the classic reference book in this field of China.
Professor Wang Zhenyi has cultivated 21 doctors, 34 postgraduates, two of which have become academicians. In China, Professor Wang has won the first Ho Leung Ho Lee Award of Scientific and Technological Achievement, the Qiu Shi Outstanding Scientist Award, the prize of Hero in Education of Shanghai and the title of Advanced Worker in National Health System.
At the meeting of National Science & Technology Awards, ten projects of SJTU were praised by the Party Central Committee and the State Council, among which five were completed as the first contributor. The five projects are: “New Mechanism of’ Differentiation and Apoptosis in Leukemia Cells” which won the second prize of the National Award for Natural Sciences; “Solar Air Conditioner and Efficient Heating Devices and Application” which won the second prize of the National Award for Technological Invention; “the Basic Research and Clinical Practice of Nutrition Support for Newborns with Severe Diseases” which won the second prize of the National Award for Science and Technology Progress; “Research on Key Techniques of Multimodal Approach to Part Live Transplantation and its Clinical Practice” which won the second prize of the National Award for Science and Technology Progress; “Research on the Clinical Treatment of Oral and Maxillofacial Hemangioma and Vascular Malformation” which won the second prize of the National Award for Science and Technology Progress.